• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与中医证候:脾虚患者粪便微生物群的改变。

Gut microbiota and Chinese medicine syndrome: altered fecal microbiotas in spleen (Pi)-deficient patients.

机构信息

School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

出版信息

J Tradit Chin Med. 2020 Feb;40(1):137-143.

PMID:32227775
Abstract

OBJECTIVE

To investigate the fecal microbiota changes in patients with spleen (Pi)-deficiency (SPD), a common Chinese medicine syndrome with digestive and absorptive disturbances and to provide insight into the relationship between Chinese medicine syndrome and gut dysbiosis.

METHODS

Fecal microbiotas from the stool samples of 53 SPD patients and 35 healthy subjects were analyzed via 16S rRNA gene polymerase chain reaction (PCR)-denaturation gradient gel electrophoresis (DGGE). SPD-related marker genes from 20 SPD patients and 20 healthy subjects were identified through gene sequencing, while some genes were quantified using quantitative PCR (qPCR). Discriminant analysis was conducted using SPSS software, and the canonical discriminant function formula for Pi-deficiency was established.

RESULTS

Alterations in microbiota diversity and composition between the SPD and healthy groups were demonstrated via 16S rRNA gene PCR-DGGE combined with multivariate statistical analysis. Fecal microbiota changes were also observed among different SPD-subtype patients. Eight SPD-related markers were found, and putative species corresponding to these markers were identified through gene sequencing, which may have potential associations with the common digestive dysfunctions in SPD patients. qPCR methods were established for two of these markers, which were significantly altered in the SPD patients. The canonical discriminant function formula was calculated for SPD, and the validity rates of these markers were over 85%.

CONCLUSION

Fecal microbiotas are altered in patients with SPD, which may provide insight for further studies on clinically diagnosing and treating SPD. The results may also provide data to gain a better understanding of Traditional Chinese Medicine syndrome and gut dysbiosis.

摘要

目的

研究脾虚证(SPD)患者粪便微生物群的变化,脾虚证是一种常见的中医证候,伴有消化和吸收障碍,并深入了解中医证候与肠道菌群失调的关系。

方法

采用 16S rRNA 基因聚合酶链反应(PCR)-变性梯度凝胶电泳(DGGE)分析 53 例 SPD 患者和 35 例健康对照者的粪便微生物群。通过基因测序从 20 例 SPD 患者和 20 例健康对照者中鉴定 SPD 相关标记基因,同时使用定量 PCR(qPCR)定量部分基因。使用 SPSS 软件进行判别分析,并建立脾虚证的典型判别函数公式。

结果

16S rRNA 基因 PCR-DGGE 结合多变量统计分析表明,SPD 组和健康组之间的微生物多样性和组成发生了变化。不同 SPD 亚型患者的粪便微生物群也发生了变化。发现了 8 个 SPD 相关标记物,并通过基因测序鉴定了这些标记物对应的假定种,这些种可能与 SPD 患者常见的消化功能障碍有关。为其中两个标记物建立了 qPCR 方法,这些标记物在 SPD 患者中明显改变。计算了 SPD 的典型判别函数公式,这些标记物的有效率超过 85%。

结论

SPD 患者粪便微生物群发生改变,这可能为进一步研究 SPD 的临床诊断和治疗提供依据。结果还可能为更好地理解中医证候和肠道菌群失调提供数据。

相似文献

1
Gut microbiota and Chinese medicine syndrome: altered fecal microbiotas in spleen (Pi)-deficient patients.肠道微生物群与中医证候:脾虚患者粪便微生物群的改变。
J Tradit Chin Med. 2020 Feb;40(1):137-143.
2
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
3
Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.肠道微生物群有助于溃疡性结肠炎两种中医证候的区分。
World J Gastroenterol. 2019 Jul 7;25(25):3242-3255. doi: 10.3748/wjg.v25.i25.3242.
4
Analysis of Gut Microbiota Composition in Lung Adenocarcinoma Patients with TCM Qi-Yin Deficiency.肺腺癌气阴两虚证患者肠道微生物群组成分析
Am J Chin Med. 2021;49(7):1667-1682. doi: 10.1142/S0192415X21500786. Epub 2021 Sep 7.
5
Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.中药治疗对慢性不可预测轻度应激诱导的抑郁样行为的影响:肠道微生物群和肠道微生物组功能。
Food Funct. 2019 Sep 1;10(9):5886-5897. doi: 10.1039/c9fo00399a. Epub 2019 Aug 29.
6
Molecular Characterization Of Fecal Microbiota Of Healthy Chinese Tobacco Smoker Subjects In Shaanxi Province, Xi'an China.中国陕西省西安市健康中国烟草吸烟者粪便微生物群的分子特征
J Ayub Med Coll Abbottabad. 2017 Jan-Mar;29(1):3-7.
7
Fecal Microbiota Taxonomic Shifts in Chinese Multiple Myeloma Patients Analyzed by Quantitative Polimerase Chain Reaction (QPCR) and 16S rRNA High-Throughput Sequencing.基于定量聚合酶链反应(QPCR)和 16S rRNA 高通量测序分析中国多发性骨髓瘤患者粪便微生物分类群变化。
Med Sci Monit. 2019 Nov 3;25:8269-8280. doi: 10.12659/MSM.919988.
8
Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.洞察泛微生物组解析中国腹泻型肠易激综合征患者肠道微生物群的特征性失调。
Chin Med J (Engl). 2019 Apr 20;132(8):889-904. doi: 10.1097/CM9.0000000000000192.
9
Real-time monitoring of HT29 epithelial cells as an in vitro model for assessing functional differences among intestinal microbiotas from different human population groups.将HT29上皮细胞作为体外模型实时监测,以评估不同人群肠道微生物群之间的功能差异。
J Microbiol Methods. 2018 Sep;152:210-216. doi: 10.1016/j.mimet.2018.07.003. Epub 2018 Jul 10.
10
The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway.保元汤通过肠-心轴代谢途径对心脏的保护作用。
Phytomedicine. 2020 Dec;79:153322. doi: 10.1016/j.phymed.2020.153322. Epub 2020 Sep 2.

引用本文的文献

1
Correlation of intestinal bacteria, fungi and dietary nutrient intake in NAFLD patients with spleen deficiency syndrome.非酒精性脂肪性肝病脾虚证患者肠道细菌、真菌与膳食营养摄入的相关性
Front Cell Infect Microbiol. 2025 Aug 11;15:1586212. doi: 10.3389/fcimb.2025.1586212. eCollection 2025.
2
Efficacy of Heshouwu () on gut mircobiota in mice with autoimmune encephalomyelitis.何首乌()对实验性自身免疫性脑脊髓炎小鼠肠道微生物群的影响。
J Tradit Chin Med. 2023 Aug;43(4):676-685. doi: 10.19852/j.cnki.jtcm.2023.04.001.
3
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine.
肠道微生物群与衰老:中医与西医。
Clin Interv Aging. 2023 Jun 17;18:963-986. doi: 10.2147/CIA.S414714. eCollection 2023.
4
Polysaccharides from Pseudostellaria heterophylla modulate gut microbiota and alleviate syndrome of spleen deficiency in rats.玉竹多糖通过调节肠道微生物群缓解脾虚大鼠的脾虚综合征。
Sci Rep. 2022 Nov 23;12(1):20217. doi: 10.1038/s41598-022-24329-9.
5
The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends.中医药与肠道微生物群相互作用:全球研究现状与趋势。
Front Cell Infect Microbiol. 2022 Sep 12;12:1005730. doi: 10.3389/fcimb.2022.1005730. eCollection 2022.
6
Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome.疾病相关的菌群失调和肠道微生物组中黏液降解菌阿克曼氏菌的潜在治疗作用。
Folia Microbiol (Praha). 2022 Dec;67(6):811-824. doi: 10.1007/s12223-022-00973-6. Epub 2022 May 20.
7
Esterases From Exhibit the Conversion of Albiflorin in Gut Microbiota.来自[具体来源未提及]的酯酶在肠道微生物群中表现出白花芍药苷的转化。
Front Microbiol. 2022 Apr 6;13:880118. doi: 10.3389/fmicb.2022.880118. eCollection 2022.
8
Elucidation of the Reinforcing Spleen Effect of Jujube Fruits Based on Metabolomics and Intestinal Flora Analysis.基于代谢组学和肠道菌群分析阐明大枣增强脾脏功能的作用。
Front Cell Infect Microbiol. 2022 Mar 24;12:847828. doi: 10.3389/fcimb.2022.847828. eCollection 2022.
9
Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation.益肾清热活络颗粒治疗慢性肾脏病的网络药理学分析及实验验证。
Drug Des Devel Ther. 2022 Mar 24;16:769-787. doi: 10.2147/DDDT.S348335. eCollection 2022.
10
Impact of Buzhong Yiqi Prescription on the Gut Microbiota of Patients with Obesity Manifesting Polycystic Ovarian Syndrome.补中益气方对肥胖型多囊卵巢综合征患者肠道菌群的影响
Evid Based Complement Alternat Med. 2021 Mar 15;2021:6671367. doi: 10.1155/2021/6671367. eCollection 2021.